These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 6241591)

  • 61. [Short-term intensive therapy of destructive pulmonary tuberculosis].
    Bondarev IM; Zhigalina LI; Kunichan AD
    Probl Tuberk; 1980 Dec; (12):57-9. PubMed ID: 7220536
    [No Abstract]   [Full Text] [Related]  

  • 62. [Possibilities of reducing the hospital-stage chemotherapy of patients with fibro-cavernous pulmonary tuberculosis].
    Naubet'iarova AN; Alibekova MKh
    Probl Tuberk; 1985; (3):38-40. PubMed ID: 4011589
    [No Abstract]   [Full Text] [Related]  

  • 63. [Results of intravenous chemotherapy in destructive pulmonary tuberculosis patients].
    Ursov IG; Borovinskaia TA
    Vrach Delo; 1981 Feb; (2):74-7. PubMed ID: 7222618
    [No Abstract]   [Full Text] [Related]  

  • 64. [Intermittent chemotherapy of tuberculosis in Kolín District].
    Danková D; Drapela J; Krivánek J
    Probl Tuberk; 1979 Oct; (10):9-12. PubMed ID: 504114
    [No Abstract]   [Full Text] [Related]  

  • 65. [Current chemotherapy of tuberculosis and its effectiveness in Bulgaria].
    Radanov R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(4):237-40. PubMed ID: 6278567
    [No Abstract]   [Full Text] [Related]  

  • 66. The chemotherapy of tuberculosis in Bulgaria today.
    Nitchev V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):156-8. PubMed ID: 2999953
    [No Abstract]   [Full Text] [Related]  

  • 67. [A survey on the duration of chemotherapy for pulmonary tuberculosis patients in Japan (author's transl)].
    Kekkaku; 1978 Sep; 53(9):471-6. PubMed ID: 713226
    [No Abstract]   [Full Text] [Related]  

  • 68. [Isoniazid pharmacokinetics in the combined chemotherapy of tuberculosis].
    Sokolova GB; Vilenskaia RN; Ivleva AIa; Galenko NN; Ziia AV
    Probl Tuberk; 1981 Oct; (10):24-8. PubMed ID: 7312844
    [No Abstract]   [Full Text] [Related]  

  • 69. [Clinical and epidemiological aspects of controlled short-term chemotherapy].
    Khomenko AG
    Probl Tuberk; 1998; (4):16-20. PubMed ID: 9771030
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Combined therapy of pulmonary tuberculosis by using recombinant interleukins].
    Skvortsova LA; Pavlova MV; Vinogradova TI; Archakova LI
    Probl Tuberk Bolezn Legk; 2003; (10):9-12. PubMed ID: 14669620
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Effects of intermittent short-course chemotherapy under full-course supervision on the treatment of smear positive pulmonary tuberculosis].
    Yan S; Ye H; Lin S
    Zhonghua Jie He He Hu Xi Za Zhi; 1996 Apr; 19(2):104-6. PubMed ID: 9388851
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chemotherapy of the mycobacterial diseases--leprosy and tuberculosis.
    Krenzien HN
    Indian J Chest Dis Allied Sci; 1982; 24(2-3):223-32. PubMed ID: 6762341
    [No Abstract]   [Full Text] [Related]  

  • 73. Short-course chemotherapy of tuberculosis: the Nicaraguan experience 1984-1987.
    Arguello L; Castillo O; Chavarria J; Cuadra I; Heldal E
    Bull Int Union Tuberc Lung Dis; 1989 Sep; 64(3):47-9. PubMed ID: 2627589
    [No Abstract]   [Full Text] [Related]  

  • 74. [Treatment of patients with pulmonary tuberculosis with antitubercular preparations and levamisole].
    Feuereisl R; Papezová E
    Probl Tuberk; 1988; (3):31-3. PubMed ID: 3290887
    [No Abstract]   [Full Text] [Related]  

  • 75. Retreatment of pulmonary tuberculosis.
    Agarwal K; Roy DC; Matah SC; Sunder S
    J Assoc Physicians India; 1985 Dec; 33(12):814-6. PubMed ID: 3837007
    [No Abstract]   [Full Text] [Related]  

  • 76. Treating tuberculosis in children.
    Steiner P; Rao M; Victoria MS
    N Engl J Med; 1977 Oct; 297(17):946. PubMed ID: 302912
    [No Abstract]   [Full Text] [Related]  

  • 77. [Microbiological methods in selection of optimal drug combinations in complex treatment of destructive pulmonary tuberculosis].
    Dolzhanskiĭ VM; Sagalovich VIa; Girin DV; Kaplov LP
    Probl Tuberk; 1978 Sep; (9):64-9. PubMed ID: 704601
    [No Abstract]   [Full Text] [Related]  

  • 78. [Results obtained with the first group of tuberculosis patients included in short-duration intensive treatment].
    Jugănaru V; Dănilă F; Niţu E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989; 38(2):181-4. PubMed ID: 2555906
    [No Abstract]   [Full Text] [Related]  

  • 79. Short-course chemotherapy of pulmonary tuberculosis: a new approach to drug dosage in the initial intensive phase.
    Gangadharam PR
    Am Rev Respir Dis; 1987 Dec; 136(6):1518. PubMed ID: 3688656
    [No Abstract]   [Full Text] [Related]  

  • 80. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens].
    Muratov VV; Pashkov IuN; Pospelov VV
    Probl Tuberk; 1981 Dec; (12):30-4. PubMed ID: 6801646
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.